Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Aug;52(8):2075–2082. doi: 10.1172/JCI107392

Abnormal Lipoprotein Lipase in Familial Exogenous Hypertriglyceridemia

Paul H Schreibman 1,2, Daniel L Arons 1,2, Christopher D Saudek 1,2, Ronald A Arky 1,2
PMCID: PMC302490  PMID: 4719678

Abstract

A 5-yr old male proband and his sister have had hypertriglyceridemia and hepatosplenomegaly since birth. When studied on a metabolic ward, they demonstrated rapid decreases in serum triglycerides on 3 g fat/day diets. Oral glucose tolerance tests were normal. Postheparin lipolytic activity (PHLA) against chylomicrons was virtually absent in both children whereas the mother and a normolipemic sister had levels approximately 50% normal. However, all four had a normal PHLA against commercial triglyceride emulsion (Intralipid). Two unrelated children from different kindreds of typical type 1 hyperlipoproteinemia and two patients with acquired type V hyperlipoproteinemia had deficient PHLA against both substrates. No inhibitors of PHLA could be demonstrated in the proband's plasma, and his own PHLA could not be enhanced by either normal concentrated plasma or pooled d > 1.063 lipoprotein fraction. The proband's postheparin plasma required almost 20 times the normal chylomicron-triglyceride concentration to reach one-half maximal lipase velocity.

Both affected siblings showed heavy pre-beta lipoprotein electrophoretic bands plus chylomicrons in their fasting plasmas while ingesting a 33% carbohydrate, 30% fat diet. Incubation of their postheparin plasma with Sf > 400 chylomicrons in vitro produced a smaller Sf 20-400 “remnant” with pre-beta electrophoretic mobility that was not seen under the same conditions when normal postheparin plasma was used. Postheparin monoglyceridase and phospholipase activities were either normal or only moderately decreased when determined with appropriate artificial substrates. These data are consistent with either (a) a mutant gene producing a lipoprotein lipase with unusual substrate specificities or (b) an absolute deficiency of normal lipoprotein lipase with a compensatory increase in some other postheparin triglyceridase.

Full text

PDF
2075

Images in this article

2078Image
on p.2078
2078Image
on p.2078
2079Image
on p.2079

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHRENS E. H., Jr, HIRSCH J., OETTE K., FARQUHAR J. W., STEIN Y. Carbohydrate-induced and fat-induced lipemia. Trans Assoc Am Physicians. 1961;74:134–146. [PubMed] [Google Scholar]
  2. Biale Y., Shafrir E. Lipolytic activity toward tri- and monoglycerides in postheparin plasma. Clin Chim Acta. 1969 Mar;23(3):413–419. doi: 10.1016/0009-8981(69)90341-6. [DOI] [PubMed] [Google Scholar]
  3. Bimpson T., Higgins J. A. The effect of pH, sodium chloride and protamine sulphate on the formation of a complex between rat adipose-tissue lipoprotein lipase and chylomicrons. Biochim Biophys Acta. 1969 Oct 28;187(3):447–449. doi: 10.1016/0005-2760(69)90021-6. [DOI] [PubMed] [Google Scholar]
  4. Bradford R. H., Furman R. H., Bass H. B. Plasma post-heparin lipolytic activity in hyperchylomi-cronemia (fat-induced lipemia). Biochim Biophys Acta. 1968 Oct 22;164(2):172–184. doi: 10.1016/0005-2760(68)90144-6. [DOI] [PubMed] [Google Scholar]
  5. Carter J. R., Jr Hepatic lipase in the rat. Biochim Biophys Acta. 1967 Feb 14;137(1):147–156. doi: 10.1016/0005-2760(67)90018-5. [DOI] [PubMed] [Google Scholar]
  6. DATTA D. V., WIGGINS H. S. NEW EFFECTS OF SODIUM CHLORIDE AND PROTAMINE ON HUMAN POSTHEPARIN PLASMA 'LIPOPROTEIN' LIPASE ACTIVITY. Proc Soc Exp Biol Med. 1964 Mar;115:788–792. doi: 10.3181/00379727-115-29039. [DOI] [PubMed] [Google Scholar]
  7. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FREDRICKSON D. S., ONO K., DAVIS L. L. LIPOLYTIC ACTIVITY OF POST-HEPARIN PLASMA IN HYPERGLYCERIDEMIA. J Lipid Res. 1963 Jan;4:24–33. [PubMed] [Google Scholar]
  9. Fielding C. J. Human lipoprotein lipase. I. Purification and substrate specificity. Biochim Biophys Acta. 1970 Apr 22;206(1):109–117. doi: 10.1016/0005-2744(70)90087-2. [DOI] [PubMed] [Google Scholar]
  10. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 5;276(1):34–contd. doi: 10.1056/NEJM196701052760107. [DOI] [PubMed] [Google Scholar]
  11. Greten H., Levy R. I., Fredrickson D. S. Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. J Lipid Res. 1969 May;10(3):326–330. [PubMed] [Google Scholar]
  12. Guder W., Weiss L., Wieland O. Triglyceride breakdown in rat liver. The demonstration of three different lipases. Biochim Biophys Acta. 1969;187(2):173–185. doi: 10.1016/0005-2760(69)90025-3. [DOI] [PubMed] [Google Scholar]
  13. HAVEL R. J., GORDON R. S., Jr Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest. 1960 Dec;39:1777–1790. doi: 10.1172/JCI104202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harlan W. R., Jr, Winesett P. S., Wasserman A. J. Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat. J Clin Invest. 1967 Feb;46(2):239–247. doi: 10.1172/JCI105526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hazzard W. R., Porte D., Jr, Bierman E. L. Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia). J Clin Invest. 1970 Oct;49(10):1853–1858. doi: 10.1172/JCI106403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Higgins J. A., Green C. Properties of a lipase of rat-liver parenchymal cells. Biochim Biophys Acta. 1967 Oct 2;144(2):211–220. doi: 10.1016/0005-2760(67)90151-8. [DOI] [PubMed] [Google Scholar]
  17. LEES R. S., HATCH F. T. Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med. 1963 Mar;61:518–528. [PubMed] [Google Scholar]
  18. Redgrave T. G. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest. 1970 Mar;49(3):465–471. doi: 10.1172/JCI106255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SHORE B., SHORE V. Heparin-released lipolytic and esterolytic activities of human and rabbit plasmas. Am J Physiol. 1961 Nov;201:915–922. doi: 10.1152/ajplegacy.1961.201.5.915. [DOI] [PubMed] [Google Scholar]
  20. Steiner G. Lipoprotein lipase in fat-induced hyperlipemia. N Engl J Med. 1968 Jul 11;279(2):70–74. doi: 10.1056/NEJM196807112790204. [DOI] [PubMed] [Google Scholar]
  21. VOGEL W. C., ZIEVE L. POST-HEPARIN PHOSPHOLIPASE. J Lipid Res. 1964 Apr;5:177–183. [PubMed] [Google Scholar]
  22. Vogel W. C., Bierman E. L. Correlation between post-heparin lipase and phospholipase activities in human plasma. Lipids. 1970 Apr;5(4):385–391. doi: 10.1007/BF02532103. [DOI] [PubMed] [Google Scholar]
  23. Wilson D. E., Schreibman P. H., Arky R. A. Post-heparin lipolytic activity in diabetic patients with a history of mixed hyperlipemia. Relative rates against artificial substrates and human chylomicrons. Diabetes. 1969 Aug;18(8):562–566. doi: 10.2337/diab.18.8.562. [DOI] [PubMed] [Google Scholar]
  24. Wilson D. E., Schreibman P. H., Brewster A. C., Arky R. A. The enhancement of alimentary lipemia by ethanol in man. J Lab Clin Med. 1970 Feb;75(2):264–274. [PubMed] [Google Scholar]
  25. ZLATKIS A., ZAK B., BOYLE A. J. A new method for the direct determination of serum cholesterol. J Lab Clin Med. 1953 Mar;41(3):486–492. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES